News Focus
News Focus
icon url

biosectinvestor

03/17/22 4:37 PM

#452257 RE: flipper44 #452256

If it were true, and I have no reason to believe his post at the moment, how would he know this to be true?

You have some very long lived patients that I believe were some of the first, Jennifer Sugioka, Brad Silver, Jeannine Waldron, just to name a few of those who are long-term survivors who have been seen not that long ago.

Plus there has been a pandemic that has been particularly hard on cancer survivors. So the comment on his belief, which is not factual, Carrie’s very little weight.
icon url

IkeEsq

03/17/22 4:38 PM

#452258 RE: flipper44 #452256

Yeah, I get that piece now, reading other comments, so I edited my response just to be clearer. Thanks!
icon url

skitahoe

03/17/22 4:44 PM

#452261 RE: flipper44 #452256

Flipper,

As I understand it a DCVax-Direct trial ought to permit far faster enrollment than DCVax-L as no surgery is needed. If they continued looking at patients with all sorts of solid cancers that are inoperable, lining up thousands of patients would be possible. The question is where does the money come from to do it. If they either get a partnership, or many more shares authorized with data that takes the share price substantially higher, perhaps a substantially sized pivotal trial could be next.

Gary